John Phoenix, MSN, APRN, FNP-C

APRN/Chief Medical Officer
Huntridge Family Clinic

Disclosure(s): Gilead Sciences: Advisor/Consultant, Honoraria, speaker bureau, research funding; Janssen Pharmaceutical: Advisor/Consultant, Honoraria; Lupin Pharmaceuticals: Advisor/Consultant, Honoraria; Napo pharmaceutical: Honoraria, speaker bureau; Scinexis: Advisor/Consultant, Honoraria; ViiV Healthcare: Advisor/Consultant, Honoraria, speaker bureau, clinical research funding

Poster(s):

• 1288 - US Healthcare Provider Perspectives on the initiation of cabotegravir and rilpivirine long-acting (CAB+RPV LA) in an observational real-world study (BEYOND)
  Friday, October 21, 2022

  12:15 PM – 1:30 PM US ET